tiprankstipranks
Pharma Mar SA (ES:PHM)
BME:PHM
Holding ES:PHM?
Track your performance easily

Pharma Mar SA (PHM) Financial Statements

11 Followers

Pharma Mar SA Financial Overview

Pharma Mar SA's market cap is currently ―. The company's EPS TTM is €0.035; its P/E ratio is 2,141.64; and it has a dividend yield of 0.92%. Pharma Mar SA is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total RevenueC$ 54.94M----
Gross ProfitC$ 48.71M---C$ -23.95K
EBITC$ 4.91MC$ -716.55KC$ -1.10MC$ -414.86KC$ -415.00K
EBITDAC$ 6.97M----
Net Income Common StockholdersC$ 5.98M---C$ -415.00K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 182.42MC$ 0.00C$ 0.00C$ 0.00C$ 5.97M
Total AssetsC$ 393.26M---C$ 11.58M
Total DebtC$ 42.63MC$ 0.00C$ 0.00C$ 0.00C$ 23.95K
Net DebtC$ -139.79MC$ 0.00C$ 0.00C$ 0.00C$ -5.95M
Total LiabilitiesC$ 170.30M---C$ 109.83K
Stockholders EquityC$ 222.96MC$ 0.00C$ 0.00C$ 0.00C$ 11.47M
Cash Flow-
Free Cash FlowC$ -8.30MC$ -1.10MC$ -394.26KC$ -384.25KC$ -1.05M
Operating Cash FlowC$ -2.07M---C$ -1.05M
Investing Cash FlowC$ 19.34M---C$ -37.70K
Financing Cash FlowC$ 3.16M---C$ 299.00
Currency in CAD

Pharma Mar SA Earnings and Revenue History

Pharma Mar SA Debt to Assets

Pharma Mar SA Cash Flow

Pharma Mar SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis